I'm currently advising a research unit at a university hospital that is standardizing their literature review process. Their primary use case is conducting systematic and scoping reviews for clinical evidence synthesis. The team has narrowed their search to Elicit and Consensus, but the decision hinges on practical workflow integration and long-term cost-effectiveness.
Based on a preliminary evaluation, here are the key differentiators for a healthcare context:
**Core Function & Data Sources**
* **Elicit** operates primarily on the Semantic Scholar corpus. Its strength is in automating the initial screening of vast numbers of papers by extracting key claims, interventions, and outcomes directly onto a spreadsheet-like interface. It is less a search engine and more a bulk data extraction tool for the "screening" phase.
* **Consensus** is built on a broader base, querying peer-reviewed literature directly. Its value is in using AI to surface direct answers to specific, nuanced questions (e.g., "What is the effect of intervention X on patient population Y?"), complete with citations and consensus metrics. It functions more like a targeted Q&A system.
**Workflow & TCO Considerations**
For a systematic review team, the phases are: 1) Broad search, 2) Title/Abstract screening, 3) Full-text review, 4) Data extraction.
* Elicit is most potent for phase 2, potentially reducing screening time by 50-70% based on my observations of similar teams. However, it may require more precise initial query engineering.
* Consensus appears more useful in phase 1 (exploring the landscape) and phase 3 (quickly extracting answers from full-text PDFs for inclusion). Its consensus scores can help identify prevailing findings.
The major cost variable isn't just subscription price, but researcher hours saved. A team doing 4-5 reviews annually might justify Elicit's cost if it compresses months of screening. A team asking highly specific, one-off clinical questions may find Consensus's pay-per-query model more economical.
My open question for the community: For those who have conducted formal, PRISMA-guided reviews in healthcare, where did these tools introduce the most friction or require the most manual validation? I'm particularly interested in real data on precision/recall rates for clinical terminology in each platform.
- Mark
independent eye
I'm a research operations lead for a consortium of three mid-sized hospitals. We handle about 15-20 systematic/scoping reviews annually and currently run Elicit in production for bulk screening, paired with traditional tools for the rest of the process.
1. **Total cost gets weird after year one.** Elicit's pricing is straightforward at $10/user/month (billed annually) for teams. Consensus's "Premium" is $8.99/user/month. The hidden cost is in query limits. Consensus caps you at 200 AI credits/month on that plan, where one detailed question costs one credit. For a full review, you'll burn through that in two days and need a custom quote, which they don't publish. Elicit has a 12,000 paper/month limit on the team plan, which is high but you can hit it if you're running parallel reviews.
2. **Deployment is just login, integration is the real work.** Neither tool has an API for programmatic access you'd want for automation. You manually export CSV from Elicit or copy answers from Consensus. The real integration effort is process change: training clinicians to trust Elicit's extractions or to phrase questions for Consensus in a way that doesn't introduce bias. Plan for 3-4 weeks of adjustment.
3. **Consensus breaks on complex, multi-faceted clinical questions.** If you ask "What is the effect of X on mortality in population Y with comorbidity Z," it often latches onto the most cited simple answer and misses niche studies. It's a consensus engine, by design. For scoping reviews where you need to map divergent evidence, that's a problem. Elicit breaks if you need deep, narrative synthesis. It gives you data points, not answers.
4. **Vendor lock-in is about your data, not the tool.** You can leave either anytime. The lock-in is workflow. If you build your screening phase around Elicit's spreadsheet, leaving means retraining staff on a new screening interface. If you build your question-answering phase around Consensus, leaving means losing that "quick answer" function entirely. Your sunk cost is procedural, not technical.
My pick is Elicit, but only if your primary pain point is the title/abstract screening phase for high-volume systematic reviews. If your team's bottleneck is quickly answering specific, settled clinical questions for background sections, then Consensus. To make the call clean, tell us your average number of papers per review at the screening stage, and what percentage of your review questions are fact-based versus exploratory.
Trust but verify.